Complement activation by bacterial surface glycolipids: a study with planar bilayer membranes

The complement system is a key part of innate immunity, but its activation mechanisms by bacterial surface molecules remain unclear. Prior research has shown that Gram-negative bacteria trigger complement via lipopolysaccharides (LPS), but the specific pathways involved are not fully understood. While it is known that LPS can activate the classical and alternative pathways, the role of specific functional groups in glycolipids is uncertain. This gap motivated the use of reconstituted membrane models to study how different glycolipids activate complement. No prior work had resolved whether the carboxyl group in glycolipids is essential for complement activation. Existing studies have focused on whole bacteria or crude extracts, making it difficult to isolate individual lipid effects. This paper's contribution lies in using planar bilayers to mimic bacterial outer membranes and directly measure complement pore formation. The study addresses the unresolved question of how specific glycolipid structures influence complement pathway activation.

This study aimed to determine how bacterial surface glycolipids activate the human complement system. The specific problem addressed was the lack of clarity about which complement pathways are triggered by different glycolipid structures. The motivation was to identify whether LPS and glycosphingolipids (GSLs) activate the classical or alternative pathway. The researchers used planar bilayer membranes to reconstitute bacterial outer membranes for controlled experiments. They tested LPS from Salmonella and E. coli, along with GSLs from Sphingomonas. The study sought to clarify the role of the carboxyl group in complement activation. By comparing LPS and GSL derivatives, the authors aimed to distinguish between pathway-specific responses. This approach allowed for precise measurement of complement pore formation without interference from other bacterial components.

The researchers used planar asymmetric bilayer membranes to model bacterial outer membranes. These membranes contained glycolipids such as LPS and GSLs from various bacterial sources. Whole human serum was added to initiate complement activation. Membrane current changes were measured to detect pore formation. The study included LPS from Salmonella and E. coli, as well as GSL-1 from Sphingomonas. Derivatives of GSL-1 were used to test the role of the carboxyl group. The presence of C9 was confirmed to ensure pore formation was due to complement. The setup allowed for controlled addition of serum and real-time monitoring of membrane conductance. This method enabled direct observation of complement activity without whole bacteria.

All tested glycolipids caused a significant increase in membrane current after serum addition. This increase was attributed to lytic pore formation by the complement system. Pore formation required C9, confirming complement involvement. Re LPS and Rd2 LPS activated the classical pathway independently of anti-LPS antibodies. At low serum concentrations (0.2% v/v), GSL-1 and its methylester derivative activated the alternative pathway. Carboxyl-reduced GSL-1, however, activated the classical pathway. These results suggest that glycolipid structure determines complement pathway activation. The presence of a carboxyl group influenced pathway selection in GSLs.

The authors concluded that bacterial glycolipids activate complement via distinct pathways. Re LPS and Rd2 LPS triggered classical pathway activation. In contrast, GSL-1 and its methylester derivative activated the alternative pathway. Carboxyl-reduced GSL-1 activated the classical pathway, showing that structural modifications can shift pathway preference. The study suggests that the carboxyl group is a functional determinant in complement activation. The results indicate that LPS and GSLs differ in their complement activation mechanisms. The findings support the idea that pathway selection depends on glycolipid structure. The observed pore formation was dependent on C9, confirming complement involvement. The data imply that bacterial surface glycolipids can modulate immune responses through pathway-specific activation.